AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23988786
Drug: 2.8 mg
RxNorm normalized name: pectin 2.8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.8 mg kg(‐1) body mass of pseudoephedrine
Trial: 10493678
Drug: Anti-19 kDa
RxNorm normalized name: anti-CD11a
DrugBank: Efalizumab (DB00095)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Anti-19 kDa IgG antibodies
Trial: 10493678
Drug: Anti-19 kDa
RxNorm normalized name: anti-CD11a
DrugBank: Efalizumab (DB00095)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Anti-19 kDa IgA antibodies
Trial: 10493678
Drug: IgG antibodies
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgG antibodies to Yersinia outer membrane protein (YOP)
Trial: 10493678
Drug: IgA antibodies
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgA antibodies to YOP
Trial: 1912887
Drug: Amoxycillin 125
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 125 mg three times a day for seven days
Trial: 6348658
Drug: Tinidazole IV
RxNorm normalized name: Tinidazole
DrugBank: Tinidazole (DB00911)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tinidazole IV (1.60 g in 24 h)
Trial: 6348658
Drug: Ornidazole IV
RxNorm normalized name: ornidazole
DrugBank: Ornidazole (DB13026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ornidazole IV (4 g in 4 days)
Trial: 26068295
Drug: Denosumab treatment
RxNorm normalized name: Denosumab
DrugBank: Denosumab (DB06643)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Denosumab treatment for 4 years
Trial: 26068295
Drug: Denosumab treatment
RxNorm normalized name: Denosumab
DrugBank: Denosumab (DB06643)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Denosumab treatment for 7 years
Trial: 22841653
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of 95% tricholoroacetic acid after dilatation and curettage
Trial: 15378664
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba 240 mg daily
Trial: 11548847
Drug: Post-APBSCT rhG-CSF
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-APBSCT rhG-CSF administration (Group B and C)
Trial: 11548847
Drug: No rhG-CSF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No rhG-CSF administration (Group A)
Trial: 9740345
Drug: Unfractionated heparin/placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin/placebo
Trial: 26678636
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose edoxaban (60mg/30mg dose reduced)
Trial: 26678636
Drug: Lower dose
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dose edoxaban (30mg/15mg dose reduced)
Trial: 21917021
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg naftopidil daily
Trial: 21917021
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg silodosin daily
Trial: 18709689
Drug: Oral dehydroepiandrosterone
RxNorm normalized name: DEHYDROEPIANDROSTERONE
DrugBank: Prasterone sulfate (DB05804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dehydroepiandrosterone (DHEA) treatment (50 mg/day)
Trial: 18709689
Drug: DHEA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA treatment in vitro
Trial: 12875613
Drug: galantamine 24
RxNorm normalized name: galantamine 24 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: galantamine 24 mg/day
Trial: 1653139
Drug: Sumatriptan (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan (100 mg dispersible tablet)
Trial: 1653139
Drug: Cafergot (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cafergot (2 mg ergotamine tartrate, 200 mg caffeine)
Trial: 24014554
Drug: Intensive chelation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive chelation therapy
Trial: 24014554
Drug: Ferritin levels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferritin levels above 1800 G/L
Trial: 17020163
Drug: Divator Drogsan
RxNorm normalized name: phenylephrine hydrochloride Ophthalmic Solution [AK-Dilate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Divator Drogsan Pharmaceuticals (test formulation)
Trial: 17020163
Drug: Lipitor (reference
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipitor (reference formulation)
Trial: 15022654
Drug: Traditional Ayurvedic
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional Ayurvedic supplement
Trial: 10859081
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of intravenous ketorolac at the onset of the procedure (Group B)
Trial: 10859081
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of ketorolac mixed with local anesthetic (Group C)
Trial: 10859081
Drug: Placebo (saline)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline) injections (Group A)
Trial: 8459068
Drug: Intravenous Solu‐Medrol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Solu‐Medrol (1,000 mg for 3 days)
Trial: 8459068
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (100 mg bolus for 3 days, tapering over 14 days)
Trial: 8459068
Drug: Intravenous Solu‐Medrol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Solu‐Medrol
Trial: 3541604
Drug: Oral influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral influenza vaccine (killed vaccine, 98 ug hemagglutinin of A/Bangkok)
Trial: 3541604
Drug: Intramuscular influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular influenza vaccine
Trial: 29583015
Drug: 300 mg/day
RxNorm normalized name: alpelisib 300 mg/day (150 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/day resveratrol
Trial: 12788893
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) infusion at a rate to raise local GH to approximately 40 ng/ml for 4 hours
Trial: 12466370
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) infusion
Trial: 10657837
Drug: Abnormal pattern
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abnormal pattern of urinary excretion of LTB(4) and its metabolites
Trial: 3899818
Drug: Neutral human
RxNorm normalized name: DentiCare Neutral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutral human insulin (0.3 U/kg)
Trial: 3899818
Drug: Acid bovine
RxNorm normalized name: Pegademase Bovine
DrugBank: Pegademase (DB00061)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acid bovine soluble insulin (0.3 U/kg)
Trial: 3899818
Drug: Moderate antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate antibody levels
Trial: 3899818
Drug: Acid bovine
RxNorm normalized name: Pegademase Bovine
DrugBank: Pegademase (DB00061)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acid bovine soluble insulin
Trial: 3899818
Drug: Neutral human
RxNorm normalized name: DentiCare Neutral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutral human insulin
Trial: 21998076
Drug: Methylnaltrexone 12
RxNorm normalized name: methylnaltrexone 12 mg/0.6 mL subcutaneous kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylnaltrexone 12 mg
Trial: 25438529
Drug: High-dose milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose milk powder (55g daily)
Trial: 25438529
Drug: Low-dose milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose milk powder (33g daily)
Trial: 21711525
Drug: Action‐Observation Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Action‐Observation Therapy (UP‐CAT)
Trial: 16107949
Drug: Recombinant glycoprotein
RxNorm normalized name: Recombinant glycoprotein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant glycoprotein 120 vaccine
Trial: 3179151
Drug: 0.75% 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% 10 ml (75 mg)
Trial: 3179151
Drug: 0.5% 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% 15 ml (75 mg)
Trial: 3179151
Drug: 0.75% 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% 15 ml (112.5 mg)
Trial: 3179151
Drug: 0.75% 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% 10 ml (75 mg) in patients older than 50 years
Trial: 3179151
Drug: 0.75% 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% 15 ml (75 mg) in patients older than 50 years
Trial: 30883861
Drug: Angiotensin converting
RxNorm normalized name: Angiotensin converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin converting enzyme inhibitor
Trial: 27402210
Drug: Ultrasound therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound therapy (10 treatments)
Trial: 27402210
Drug: Shock wave
RxNorm normalized name: ELECTRODE GEL,H-WAVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shock wave therapy (4 treatments)
Trial: 23469593
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (Domperidone or Esomeprazole)
Trial: 17618958
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg Rhodiola rosea per day for 4 days
Trial: 16356089
Drug: TPOAb positive
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPOAb positive (TPOAb(+) > 100 U/ml)
Trial: 16356089
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of thyroid medication
Trial: 11940309
Drug: Ramipril treatment
RxNorm normalized name: Ramipril
DrugBank: Ramipril (DB00178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramipril treatment (n = 21)
Trial: 8594697
Drug: Single-dose diethylcarbamazine
RxNorm normalized name: diethylcarbamazine
DrugBank: Diethylcarbamazine (DB00711)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose diethylcarbamazine (DEC) 6mg/kg
Trial: 8594697
Drug: Standard regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard regimen of 6 doses (total 36 mg/kg) of DEC
Trial: 2569857
Drug: Dilevalol 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilevalol 200 mg qd
Trial: 2569857
Drug: Captopril 100
RxNorm normalized name: captopril 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 100 mg bid
Trial: 2569857
Drug: Nifedipine 40
RxNorm normalized name: nifedipine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 40 mg bid
Trial: 28431589
Drug: Albendazole plus
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole plus antiepileptic drugs
Trial: 28431589
Drug: Antiepileptic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiepileptic treatment (Control)
Trial: 16995457
Drug: No antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotic prophylaxis (group II)
Trial: 15298069
Drug: Olcegepant, a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olcegepant, a non-peptide CGRP receptor antagonist, details on dosage and duration not available
Trial: 11147785
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (20 g daily during immobilization, 15 g daily during first 3 weeks of rehabilitation, 5 g daily during last 7 weeks of rehabilitation)
Trial: 31473867
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) twice weekly for 6 weeks
Trial: 20694481
Drug: Remifentanil (group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (group R) used in combination with fentanyl as intravenous analgesic.
Trial: 20694481
Drug: Fentanyl alone
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl alone (group C) as intravenous analgesic.
Trial: 12579093
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy (cisplatin at 80 mg/m(2) on 1 day and vindesine at 3 mg/m(2) on 2 days) followed by surgery
Trial: 1958276
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (CyA, Aza, MP)
Trial: 1958276
Drug: Triple therapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy, Aza + CyA, CyA + MP
Trial: 6894708
Drug: Sustained Release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained Release (SR) formulation of butriptyline, 75 mg single oral dose
Trial: 6894708
Drug: Conventional formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional formulation of butriptyline, 75 mg single oral dose
Trial: 19329279
Drug: Novel compounds
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel compounds for SLE treatment
Trial: 17523483
Drug: Interferon preparations
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon preparations included in complex therapy for ureaplasmosis
Trial: 11881128
Drug: Candesartan 16
RxNorm normalized name: candesartan 16 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 16 mg o.d. for 24 weeks
Trial: 9773913
Drug: Propofol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2.5 mg x kg(‐1); 15 mg x kg(‐1) x hr)
Trial: 2149513
Drug: Labetalol (1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (1600 mg max daily dose)
Trial: 2149513
Drug: Propranolol (640
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (640 mg max daily dose)
Trial: 28183544
Drug: 0.45 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.45 mg/kg rocuronium plus magnesium sulfate 30 mg/kg (group LM)
Trial: 28183544
Drug: 0.6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg/kg rocuronium (group C)
Trial: 28183544
Drug: 0.45 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.45 mg/kg rocuronium (group LR)
Trial: 23591713
Drug: Cholecalciferol 7,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 7,000 IU daily for 26 weeks
Trial: 19669785
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (Cor, Cortancyl, 50 mg per day for 1 week)
Trial: 19669785
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (Cor)
Trial: 8198020
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg/d + Niacin (titrated to maximum of 3 g/d)
Trial: 3556263
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg paracetamol plus 60 mg codeine
Trial: 3556263
Drug: 650 mg
RxNorm normalized name: bran 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 650 mg paracetamol plus 65 mg dextropropoxyphene
Trial: 31604674
Drug: Ongoing Benzodiazepine
RxNorm normalized name: 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
DrugBank: Nitrazepam (DB01595)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ongoing Benzodiazepine and related drug (BDZR) use
Trial: 29214506
Drug: Oral paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral paracetamol (1000 mg) co-administered with morphine (0.125 mg/kg)
Trial: 29214506
Drug: Intravenous paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous paracetamol (1000 mg) co-administered with morphine (0.125 mg/kg)
Trial: 29214506
Drug: Oral paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral paracetamol (1000 mg) after discontinuation of morphine
Trial: 25727536
Drug: Antipsychotics (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotics (various types, including olanzapine)
Trial: 19738145
Drug: On-treatment IMT
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: On-treatment IMT values
Trial: 19738145
Drug: Treatment-induced IMT
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-induced IMT changes
Trial: 20080918
Drug: IA injection
RxNorm normalized name: factor VIIa Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IA injection of 40 mg triamcinolone acetonide
Trial: 20080918
Drug: 1 cc
RxNorm normalized name: BD Needle SG 1 cc 27g 5/8"
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 cc 0.9% saline (placebo)
Trial: 19003741
Drug: Autologous bone
RxNorm normalized name: Human autologous bone marrow derived osteoblastic cells
DrugBank: Human autologous bone marrow derived osteoblastic cells (DB18259)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous bone marrow cell treatment (injected at 40 sites into the ischemic limb)
Trial: 19003741
Drug: Placebo (sham
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (sham bone marrow punction and 40 saline injections)
Trial: 19003741
Drug: Autologous bone
RxNorm normalized name: Human autologous bone marrow derived osteoblastic cells
DrugBank: Human autologous bone marrow derived osteoblastic cells (DB18259)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous bone marrow cell treatment
Trial: 30924301
Drug: Subcision, needling,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcision, needling, and topical application of PRP
Trial: 25819042
Drug: Inosine pranobex
RxNorm normalized name: inosine pranobex
DrugBank: Inosine pranobex (DB13156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inosine pranobex (1 g four times daily)
Trial: 25819042
Drug: Acyclovir (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir (200 mg five times daily)
Trial: 21594560
Drug: Valproic acid
RxNorm normalized name: Valproic Acid
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproic acid (400 mg)
Trial: 21594560
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of D-cycloserine and Valproic acid
Trial: 11535952
Drug: Cefaclor (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor (375 mg BID for 10 days)
Trial: 11535952
Drug: Amoxicillin/clavulanate (625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate (625 mg BID for 10 days)
Trial: 9692813
Drug: 10 microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 microg/kg G‐CSF
Trial: 9692813
Drug: 24 microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 microg/kg G‐CSF
Trial: 8778145
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (AA) 1000 mg daily for 4 weeks
Trial: 7276678
Drug: Group A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A: MFC (mitomycin C, 5 fluorouracil, cytosine arabinoside) intravenously for 5 weeks, followed by oral 5 FU dry syrup for 2 years
Trial: 7276678
Drug: Group C:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C: no chemotherapy added to surgery
Trial: 24164569
Drug: SRP +
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SRP + probiotic (Lactobacillus reuteri lozenges, used two times a day for 12 weeks)
Trial: 20146674
Drug: Rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 10 mg/day (n=19)
Trial: 20146674
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg/day (n=19)
Trial: 16889324
Drug: Individual art
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individual art therapy for 1 hour/week during postoperative radiotherapy
Trial: 12911442
Drug: Multimodal smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal smoking cessation intervention (individual counseling + optional nicotine replacement therapy)
Trial: 11004357
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate (500-microg tablet vaginally, every 6 hours for maximum of two doses)
Trial: 11004357
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 (3-mg tablet vaginally, every 6 hours for maximum of two doses)
Trial: 1903167
Drug: rt-PA2 (2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rt-PA2 (2000 x 10(4)IU, 33 mg)
Trial: 1903167
Drug: rt-PA3 (3000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rt-PA3 (3000 x 10(4)IU, 50 mg)
Trial: 19882056
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg oral palm vitamin E